Jacques‐Emmanuel Galimard

1.4k total citations
27 papers, 489 citations indexed

About

Jacques‐Emmanuel Galimard is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jacques‐Emmanuel Galimard has authored 27 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Public Health, Environmental and Occupational Health and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jacques‐Emmanuel Galimard's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Jacques‐Emmanuel Galimard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Jacques‐Emmanuel Galimard collaborates with scholars based in France, Italy and Germany. Jacques‐Emmanuel Galimard's co-authors include Matthieu Resche‐Rigon, Sylvie Chevret, Mohamad Mohty, Arnon Nagler, Myriam Labopin, Camélia Protopopescu, Emmanuel Curis, Nicolaus Kröger, Ibrahim Yakoub‐Agha and Peter Bader and has published in prestigious journals such as Blood, Cancer and The Journal of Pediatrics.

In The Last Decade

Jacques‐Emmanuel Galimard

24 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques‐Emmanuel Galimard France	12	285	155	104	86	69	27	489
Elizabeth F. Krakow United States	10	145 0.5×	71 0.5×	47 0.5×	81 0.9×	16 0.2×	36	321
Geoff D.E. Cuvelier Canada	13	231 0.8×	159 1.0×	217 2.1×	86 1.0×	65 0.9×	49	651
Michael Keng United States	11	148 0.5×	106 0.7×	67 0.6×	182 2.1×	84 1.2×	52	453
D. Messerer Germany	10	258 0.9×	263 1.7×	45 0.4×	85 1.0×	12 0.2×	21	465
Andrew Hantel United States	12	123 0.4×	117 0.8×	51 0.5×	119 1.4×	40 0.6×	60	499
Eleanor M. Pinto United Kingdom	9	66 0.2×	66 0.4×	37 0.4×	89 1.0×	61 0.9×	13	515
Laura Winter United States	10	307 1.1×	171 1.1×	35 0.3×	171 2.0×	24 0.3×	20	538
Deepesh Lad India	14	265 0.9×	82 0.5×	140 1.3×	153 1.8×	44 0.6×	131	622
Bhuvana Jayaraman United States	6	69 0.2×	57 0.4×	19 0.2×	65 0.8×	49 0.7×	7	361
Pooneh Akhavan Canada	9	103 0.4×	47 0.3×	87 0.8×	19 0.2×	47 0.7×	17	599

Countries citing papers authored by Jacques‐Emmanuel Galimard

Since Specialization

Citations

This map shows the geographic impact of Jacques‐Emmanuel Galimard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques‐Emmanuel Galimard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques‐Emmanuel Galimard more than expected).

Fields of papers citing papers by Jacques‐Emmanuel Galimard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques‐Emmanuel Galimard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques‐Emmanuel Galimard. The network helps show where Jacques‐Emmanuel Galimard may publish in the future.

Co-authorship network of co-authors of Jacques‐Emmanuel Galimard

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques‐Emmanuel Galimard. A scholar is included among the top collaborators of Jacques‐Emmanuel Galimard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques‐Emmanuel Galimard. Jacques‐Emmanuel Galimard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bazarbachi, Ali, Jacques‐Emmanuel Galimard, Gérard Socié, et al.. (2025). Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP. American Journal of Hematology. 100(8). 1374–1386.

Martı́nez, Carmen, Bénédicte Deau, Hervé Ghesquières, et al.. (2025). Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group. Bone Marrow Transplantation. 60(6). 879–887.

Deau, Bénédicte, Hervé Ghesquières, Luc‐Matthieu Fornecker, et al.. (2024). Outcomes of Patients with Hodgkin Lymphoma Receiving Brentuximab Vedotin (BV) As Maintenance Therapy after ASCT According to Previous Exposure to BV. a Retrospective Analysis of the EBMT Lymphoma Working Party in Collaboration with Geltamo, FIL, Lysarc, and Turkish Lymphoma Group. Blood. 144(Supplement 1). 1663–1663. 1 indexed citations

Galimard, Jacques‐Emmanuel, Ali Bazarbachi, Jürgen Finke, et al.. (2024). Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients. Blood Cancer Journal. 14(1). 76–76. 3 indexed citations

Prata, Pedro Henrique, Jacques‐Emmanuel Galimard, Flore Sicre de Fontbrune, et al.. (2023). Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria. Blood. 141(15). 1812–1816. 7 indexed citations

Hamed, Rama Al, Jacques‐Emmanuel Galimard, Henrik Sengeloev, et al.. (2023). Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia—Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study. Cancer. 129(17). 2645–2654. 3 indexed citations

Fein, Joshua, Roni Shouval, Jacques‐Emmanuel Galimard, et al.. (2023). Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study. Blood Advances. 7(10). 2143–2152. 3 indexed citations

Galimard, Jacques‐Emmanuel, Xavier Poiré, Anne Huynh, et al.. (2023). The Impact of DNMT3A Mutation on Survival of AML Patients Receiving Allogeneic Hematopoietic Cell Transplantation in First Remission Depends on the Karyotype and Co-Occurring Mutations: On Behalf of the EBMT Acute Leukemia Working Party. Blood. 142(Supplement 1). 658–658. 1 indexed citations

Nagler, Arnon, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2022). Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT. Cancer Medicine. 12(2). 1482–1491. 5 indexed citations

10.

Nagler, Arnon, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2022). Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT. Bone Marrow Transplantation. 57(12). 1788–1796. 5 indexed citations

11.

Sanz, Jaime, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2021). Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT. Journal of Hematology & Oncology. 14(1). 84–84. 19 indexed citations

12.

Ruggeri, Annalisa, Jacques‐Emmanuel Galimard, Franca Fagioli, et al.. (2021). Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 27(5). 424.e1–424.e9. 24 indexed citations

13.

Sanz, Jaime, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2020). Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT. Journal of Hematology & Oncology. 13(1). 46–46. 60 indexed citations

14.

Baron, Frédéric, Jacques‐Emmanuel Galimard, Myriam Labopin, et al.. (2019). Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin. Haematologica. 105(4). 1138–1146. 19 indexed citations

15.

Shouval, Roni, Joshua Fein, Myriam Labopin, et al.. (2019). Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. The Lancet Haematology. 6(11). e573–e584. 129 indexed citations

16.

Galimard, Jacques‐Emmanuel, Sylvie Chevret, Emmanuel Curis, & Matthieu Resche‐Rigon. (2018). Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors. BMC Medical Research Methodology. 18(1). 90–90. 38 indexed citations

17.

Lorthe, Elsa, Pierre‐Yves Ancel, Héloïse Torchin, et al.. (2017). Impact of Latency Duration on the Prognosis of Preterm Infants after Preterm Premature Rupture of Membranes at 24 to 32 Weeks' Gestation: A National Population-Based Cohort Study. The Journal of Pediatrics. 182. 47–52.e2. 49 indexed citations

18.

Yordanov, Youri, Jacques‐Emmanuel Galimard, Sébastien Beaune, et al.. (2017). Management of upper gastrointestinal bleeding in emergency departments, from bleeding symptoms to diagnosis: a prospective, multicenter, observational study. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 25(1). 78–78. 26 indexed citations

19.

Bigenwald, Camille, Jacques‐Emmanuel Galimard, L. Quéro, et al.. (2017). Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients. Oncotarget. 8(45). 80073–80082. 11 indexed citations

20.

Galimard, Jacques‐Emmanuel, Sylvie Chevret, Camélia Protopopescu, & Matthieu Resche‐Rigon. (2016). A multiple imputation approach for MNAR mechanisms compatible with Heckman's model. Statistics in Medicine. 35(17). 2907–2920. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact